An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy
AUTOR(ES)
Mones, Robert J.
RESUMO
Six patients diagnosed as Parkinson's disease on a clinical basis alone are described, and their response to L-dopa and to alpha methyl dopa hydrazine (MK 486) and L-dopa. They are compared with 239 other patients with Parkinson's disease treated in the same time period. These six patients were unusual in that they did not have a clinical response to L-dopa, nor did they develop dyskinesias on L-dopa or on L-dopa with MK 486, although they showed high blood levels of L-dopa and high homovanillic acid levels in the spinal fluid. Unresponsiveness to L-dopa is attributed to a specific brain mechanism and not to problems of transport of L-dopa to the brain or to abnormal peripheral metabolism of L-dopa. The term `motor unresponsiveness to L-dopa' may be useful to describe such patients who may eventually be shown to be suffering from diseases other than Parkinsonism.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=494334Documentos Relacionados
- Influence of dystonia on the response to long-term L-dopa therapy in Parkinson's disease
- Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.
- Quantitative study of the effect of L-dopa and phenoxybenzamine on the rigidity of Parkinson's disease
- Analysis of l-dopa induced dyskinesias in 51 patients with Parkinsonism
- Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.
